PARIS: Romania’s Simona Halep today rounded on the International Tennis Integrity Agency (ITIA) for discrepancies in the treatment of world No 2 Iga Swiatek after testing positive for a banned substance.
The ITIA announced a one-month ban yesterday for Swiatek after the 23-year-old had tested positive for the heart medication trimetazidine (TMZ) in an out-of-competition sample in August 2024, when the Polish player was ranked No 1 in the world.
Halep, now 33, returned to tennis in March this year after her own career had been on hold since Oct 7, 2022, the date of the start of her provisional suspension after testing positive for roxadustat at the US Open.